Sentences with phrase «small biotech companies»

How about the small biotech companies in the discovery stage?

University and government departments, and small biotech companies, employ me to advise them on bioinformatics and structural biology research.

«A lot of small biotech companies have been affected by the economic situation.

It's not big pharmaceutical companies driving the demand there, he says, but small biotech companies who've realized they can capitalize on the enormous amount of publicly available health and genomics data.

She participated in collaborations with small biotech companies and big pharma.

There's also significant investment supporting small biotech companies and Linear has invested substantially in attracting both the American and Chinese markets including engaging Mandarin speaking staff, translating materials and running meetings in Mandarin.

The head of Riot Blockchain, a small biotech company - turned - crypto, has made hundreds of thousands of dollars in stock sales already.

On November 21st, a relatively small biotech company named Gilead Sciences (GILD) made headline news in the pharmaceutical investment community when it acquired a little - known hepatitis C drug developer named Pharmasset Inc. (VRUS), for $ 10.8 billion, in an all - cash deal.

Julian was also CEO of a small biotech company.

But the aspect of the work I enjoy most, and one that I think differentiates research in a small biotech company from research in larger institutions and a great many university departments, is that competition is replaced by cooperation.

«In terms of learning potential, I thought that there would be more to learn in a small biotech company than in big pharma,» he explains.

Seven years ago, when I completed my Ph.D. and joined a small biotech company, my assigned title was Scientist.

Smaller biotech company GeneMedix has a plant in Ireland.

«I think it may be up to smaller biotech companies and academia to come up with new drugs,» Littman says.

You need that kind of communication just to get anything done in a small biotech company, says Douglas Gjerde, CEO of San Jose, California - based PhyNexus.

The reason some hiring managers are more critical of industry postdocs is that a number of smaller biotech companies consider positions at the postdoc level to be «cheap pairs of hands» jobs and not independent research positions.

Jane works at BioPharmGene, a small biotech company.

So, when I go to visit a small biotech company in California that is very casual, it makes sense to be in the same kind of attire.

So I looked for postdoctoral positions as well as for positions in smaller biotech companies.

Susan Schade, a UAB alumna who now does research for a small biotech company in Birmingham, says that the IR helped her in its «exposure to different career paths and networking» and allowed her «to make contact with all kinds of people not at UAB.»

Blackwell has started a small biotech company in Madison with that as her goal — plotting a future jump in scale from plants to people.

Sure, the smaller biotech companies can be squirrelly at times, but nothing beats the odd behavior of some Fortune 100 companies.

But because they're a small biotech company, with high risk of default (i.e., a high risk of not paying off their debts), they would have to pay a very high interest rate in order to make the bond attractive enough for investors to purchase it.

These include government or private nonprofit funders of basic research, such as the National Institutes of Health in the United States or the Wellcome Trust in the United Kingdom; academic scientists; multinational pharmaceutical firms and smaller biotech companies; and, at the end of the line, government regulatory agencies responsible for drug approval.

BioSpyder Technologies, Inc. is a relatively small biotech company that features a potent assay for high - throughput gene expression profiling.

In their quest to improve therapy, scientists at Pharmasset, a small biotech company founded by Raymond Schinazi, focused on HCV's RNA - copying enzyme.

Combimatrix (Symbol: CBMX) is a small biotech company that is tremendously undervalued by the market and has catalyst in place to realize its intrinsic value in the near term (~ 6 months or less).

Around the same time the CIT deal was playing out, Klarman took a sizable stake in Facet Biotech — a small biotech company spun off in December 2008 from PDL BioPharma — for an average cost of $ 9 even though it had $ 17 per share in net cash at the time of the spinoff.

BVF, which specializes in smaller biotech companies, has become the most outspoken investor pressing for its money back.

Not exact matches

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

Instead, he did it the same way a fast - growth software or biotech company develops products — with a small team, angel funding, freewheeling management, a willingness to take big risks, and a belief that serious profit lay on the far side.

The «microbiome,» or the collection of organisms that reside within the human body (especially the gut), has become a big new interest area for a number of major pharma companies like Merck and smaller biotechs alike.

Says biotech recruiter Jackie Bandish: «For many of these guys, a small company can be a breath of fresh air.»

• Ribometrix Inc, a Greenville, N.C. - based biotech company focused on developing small molecule modulators of RNA to treat disease, raised $ 7.5 million in seed funding.

Many pharmaceutical companies continue to work on treatments for neurological diseases, as do many smaller biotech firms and academic medical research centers, and funding sources for these pursuits include private foundations as well as governments.

This part of the market, typically made up of small technology and biotech companies, often struggles to attract investors because people prefer the safety of owning shares in larger companies.

In his Transformational Technology Alert research advisory, Patrick Cox leverages his over 30 years of experience as a consultant, writer, and researcher in the tech / biotech space to bring to you the small - cap tech and medical companies with the potential to transform our lives.

Although drugs are only a small fraction of the total cost of healthcare, pharmaceutical and biotech companies have been increasingly criticized, especially during election cycles.

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and invesSmall Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and invessmall - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investors.

Finally, this ETF tends to focus on buying and holding mostly small cap biotech stocks, as the average company in this ETF has a market cap of roughly $ 2 billion, which is dwarfed but its category average market cap, which rings in closer to $ 35 billion.

While I tend to like ETFs that use equal weighing, it's important for investors to understand that smaller - cap companies tend to be a bit more volatile, and that's especially true of biotech stocks, which means this ETF might be more prone to even more volatility than a weighted - average ETF would be.

In a small biotech firm, by contrast, «you are part of the whole picture and you're more involved in what goes on in the entire company.»

The move followed the company's acquisition of another biotech, KuDOS Pharmacetuicals, in 2005 and several agreements with small biotechs to co-develop drugs.

Club Biotech also organises trips to biotech companies in the Vienna area and holds smaller scientific meetings.

The reality of the job market is that biotech companies hire in very specialized niches, and smaller fields such as bioinformatics have subcategories of their own.

The site was updated weekly and contained URLs for jobs sites from universities, colleges, hospitals, museums, companies (large and small, including biotech firms), government agencies, and all kinds of publications that advertise scientific jobs.

Secondly, he advises, take advantage of the fact that a lot of biotech companies are still small, open, and informal.

In a small to midsize biotech company, there may be two or three people whose job is exclusively to write.

To compensate, companies, in effect, outsourced early - stage research to smaller specialty pharmaceutical and biotech companies.

A study by UK - based Critical Limited, a consulting company, shows that while the number of biotech companies in Europe and the United States is almost equal, European companies are much smaller and have very few products in later stages.